Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus by Toh ZQ, Kosasih J, Russell FM, Garland SM, Mulholland EK, Licciardi PV

“…Zheng Quan Toh1,2, Jennie Kosasih,1 Fiona M Russell1,3, Suzanne M Garland4,5, Edward K Mulholland1,6, Paul V Licciardi1,21Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia; 2Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia; 3Centre for International Child Health, Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia; 4Department of Obstetrics and Gynaecology, The University of Melbourne, Parkville, Victoria, Australia; 5Regional WHO HPV Reference Laboratory, Centre for Women’s Infectious Diseases Research, The Royal Women’s Hospital, Parkville, Victoria, Australia; 6Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, University of London, London WC1E7HT, UKAbstract: Human papillomavirus (HPV) types 16 and 18 cause 70% of cervical cancer cases globally. …”
Get full text

Anogenital-Associated Papillomaviruses in Animals: Focusing on <i>Bos taurus</i> Papillomaviruses by Nanako Yamashita-Kawanishi, Takeshi Haga

“…In contrast to the diverse studies on human papillomaviruses (HPVs), information on animal PVs associated with anogenital lesions is limited. …”
Get full text

Awareness, perceptions, and choices of physicians pertaining to human papillomavirus (HPV) vaccination in India: A formative research study by Ishu Kataria, Mariam Siddiqui, Katherine Treiman, Shaylen Foley, Meenu Anand, Sutapa Biswas, Digant Shastri, Neerja Bhatla, Diksha Radhakrishnan, Pavan Mamidi, Rengaswamy Sankaranarayanan

“…A safe and effective vaccine to prevent human papillomavirus (HPV) infections, the primary cause of cervical malignancies, is available in India but multiple barriers lead to its low uptake in the country. …”
Get full text

A Novel Model for Papillomavirus-Mediated Anal Disease and Cancer Using the Mouse Papillomavirus by Simon Blaine-Sauer, Myeong-Kyun Shin, Kristina A. Matkowskyj, Ella Ward-Shaw, Paul F. Lambert

Get full text

Implementation of the human papillomavirus school-entry requirement in Puerto Rico: barriers and facilitators using the consolidated framework for implementation research by Vivian Colón-López, Roxana Soto-Abreu, Diana T. Medina-Laabes, Olga L. Díaz-Miranda, Ana P. Ortiz, Erick L. Suárez, Pamela C. Hull

“…In 2018, Puerto Rico (PR) enacted a Human papillomavirus (HPV) vaccine school-entry requirement for students ages 11 to 12. …”
Get full text

Cottontail Rabbit Papillomavirus (CRPV) Related Animal Models for Head and Neck Cancer Research: A Comprehensive Review of the Literature by Michael Bette, Robert Mandic

“…Having suitable animal models is crucial to mimic human disease states and for the successful transfer of experimental data into clinical practice. In the field of papillomavirus research, the domestic rabbit (<i>Oryctolagus cuniculus</i>) has served as an indispensable model organism for almost 100 years. …”
Get full text

Human papillomavirus infection-associated markers of the occurrence and progression of cervical intraepithelial neoplasias: from research developments to clinical practice by L. I. Korolenkova

Get full text

The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: A systematic review and meta-analysisResearch in context by Sarah J Bowden, Ilkka Kalliala, Areti A Veroniki, Marc Arbyn, Anita Mitra, Kostas Lathouras, Lisa Mirabello, Marc Chadeau-Hyam, Evangelos Paraskevaidis, James M Flanagan, Maria Kyrgiou

“…Funding: NIHR, Genesis Research Trust, Imperial Healthcare Charity, Wellcome Trust NIHR Imperial BRC, European Union's Horizon 2020 Keywords: Human papillomavirus, DNA methylation, Cervical intraepithelial neoplasia, Cervical screening, Meta-analysis…”
Get full text

Human papillomavirus vaccine delivery in Mozambique: identification of implementation performance drivers using the Consolidated Framework for Implementation Research (CFIR) by Caroline Soi, Sarah Gimbel, Baltazar Chilundo, Vasco Muchanga, Luisa Matsinhe, Kenneth Sherr

Get full text

Health care personnel’s perspectives on human papillomavirus (HPV) self-sampling for cervical cancer screening: a pre-implementation, qualitative study by Serena Xiong, De Ann Lazovich, Faiza Hassan, Nafisa Ambo, Rahel Ghebre, Shalini Kulasingam, Susan M. Mason, Rebekah J. Pratt

Subjects: “…Human papillomavirus self-sampling…”
Get full text

Research progress on the prevention and treatment of HPV infection-related diseases on mucosal sites by Xingxing MEI, Naiyu LIN, Chunguang MA, Jiande HAN

“…A number of benign and malignant diseases on the head, neck and urogenital area are associated with human papillomavirus (HPV) infection on mucosal sites. Nowadays, there are many new research findings for the treatment and prevention of these diseases, such as photodynamic therapy, local immunomodulatory therapy, immune checkpoint inhibitors, targeted therapy, preventive and therapeutic vaccines, etc. …”
Get full text

Canine and feline papillomaviruses: an update by Beatriz Medeiros-Fonseca, Beatriz Medeiros-Fonseca, Ana I. Faustino-Rocha, Ana I. Faustino-Rocha, Ana I. Faustino-Rocha, Rui Medeiros, Rui Medeiros, Rui Medeiros, Rui Medeiros, Rui Medeiros, Rui Medeiros, Paula A. Oliveira, Paula A. Oliveira, Rui M. Gil da Costa, Rui M. Gil da Costa, Rui M. Gil da Costa, Rui M. Gil da Costa

“…The present review provides readers with the more recent advances on dog and cat papillomavirus research, bringing an update on this field to both veterinary practitioners and the virology community at large.…”
Get full text

The Mouse Papillomavirus Infection Model by Jiafen Hu, Nancy M. Cladel, Lynn R. Budgeon, Karla K. Balogh, Neil D. Christensen

“…The mouse papillomavirus (MmuPV1) was first reported in 2011 and has since become a powerful research tool. …”
Get full text

Persistent Human Papillomavirus Infection by Ashley N. Della Fera, Alix Warburton, Tami L. Coursey, Simran Khurana, Alison A. McBride

Get full text

Human papillomavirus vaccination: the population impact [version 1; referees: 3 approved] by Lai-yang Lee, Suzanne M. Garland

Get full text

Molecular Epidemiology of Human Papillomavirus by Talia Hoory, Archana Monie, Patti Gravitt, T.-C. Wu

“…Human papillomavirus (HPV) has been considered to be an etiologic factor for anogenital cancers, such as cervical cancer and possibly a subset of cancers of the aerodigestive tract. …”
Get full text

Transplacental transmission of Human Papillomavirus by Serafini Eduardo P, Rombaldi Renato L, Mandelli Jovana, Zimmermann Edineia, Losquiavo Kamille P

Get full text

Awareness of human papillomavirus and reported human papillomavirus vaccine uptake in a high-risk population by Trisha L. Amboree, Jane R. Montealegre, Paige Padgett Wermuth, Osaro Mgbere, Kayo Fujimoto, Charles Darkoh

“…Introduction: Disparities in human papillomavirus (HPV) awareness and HPV vaccine uptake are likely exacerbated among racial/ethnic minority populations living in low-income areas. …”
Get full text

New Insight Into Avian Papillomavirus Ecology and Evolution From Characterization of Novel Wild Bird Papillomaviruses by Marta Canuti, Hannah J. Munro, Gregory J. Robertson, Ashley N. K. Kroyer, Sheena Roul, Davor Ojkic, Hugh G. Whitney, Andrew S. Lang

Get full text

Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region by Xavier Castellsagué, Kevin A. Ault, F. Xavier Bosch, Darron Brown, Jack Cuzick, Daron G. Ferris, Elmar A. Joura, Suzanne M. Garland, Anna R Giuliano, Mauricio Hernandez-Avila, Warner Huh, Ole-Erik Iversen, Susanne K. Kjaer, Joaquin Luna, Joseph Monsonego, Nubia Muñoz, Evan Myers, Jorma Paavonen, Punnee Pitisuttihum, Marc Steben, Cosette M. Wheeler, Gonzalo Perez, Alfred Saah, Alain Luxembourg, Heather L Sings, Christine Velicer

“…Papillomavirus Research…”
Get full text